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ABSTRACT : Fifteen patients with bilateral breast cancer were clinically analyzed 
on the basis of a result of surgical treatment, in whom eight patients had bilateral 
synchronous breast cancer, four were non-synchronous and the remaining three were 
metastatic breast cancer, respectively. 
   The prognosis of patients with bilateral breast cancer was not pessimistic, indicating 
that it depended on the disease stages of each cancer. On the other hand, it was emphasized 
that the prognosis of patients with bilateral metastatic breast cancer was extremely poor. 
Surgeons should be aware of high risk of contralateral breast cancer in careful follow-up 
following mastectomy for breast cancer. 
   It is generally accepted that patients with cancer of one breast have a higher than 
average risk of developing cancer of the opposite breast. It is not so rare that bilateral 
breast tumors are seen in an identical patient on account of the effectiveness of high 
resolution mammography and sonography in early detection. It is known that a cancer 
of one breast means the most frequent precancerous lesion of the opposite breast. 
   Bilateral breast cancer may occur in any of the following ways. 
1. Bilateral simultaneous breast cancer occurring independently in both breasts and at 
the same time (syncronous). 
2. Bilateral primary non-simultaneous breast cancer occurring independently in each breast 
but at different times (asynchronous). 
3. Bilateral secondary breast cancer occurring either simultaneously or non-simultaneously 
but as one of the manifestations of metastatic dissemination. 
   However, despite these simple definitions, there is often great difficulty in determining 
the exact type of bilateral breast cancer under consideration, in particular, identifying 
second primary cancer from metastatic one. 
   In this study, bilateral breast cancers were clinicopathologically reviewed on the basis 
of a result of surgical treatment at the First Department of Surgery, Nagasaki University 
School of Medicine.
         PATIENTS 
 During the period from January 1968 to April 
1981, 485 patients with breast cancer were sur-
gically treated in the First Department of Sur-
gery, Nagasaki University School of Medicine.
 At the same period, surgical treatments in 15 
patients with bilateral breast cancer were an-
alyzed, in whom synchronous cancer included 
four patients (0.83%) asynchronous eight (1.65%) 
and metastatic three (0.62%), respectively. 
 Four patients with bilateral simultaneous 
breast cancer were listed in Table 1.
                         Table 1. Bilateral breast cancer (Metastatic) 
           right tumor TNM operative Trim 
case age left location T N stage method n stage histology adjuvant prognosis 
 1 39 right EABCD 4 2 Mb extended 1,8 III Scirrhous. Liniac. 
    (11M) (O'ophrectomy) 5Fu 
     40 left A 2 lb II limited 1,8 II meta. aden. 5FuDS 7M dead 
 2 38 right E 2 lb II standard l9 II Tele-c. 
    (7M) 
      38 left A 2 lb II O'ophrectomy meta. aden. 5Fu 5M dead 
                                                   MMC 
 3 25 left CA 2 lb II limited 1Q II Solid-tub. MMC 
    (6M) (g) TAM 
     26 right BD 4 lb Ulb meta. aden. CAF 6M alive 
                                                       MPA 
        Solid-tub.: solid-tubular carcinoma Schirrous.: scirrhous carcinoma 
        meta. aden.: metastatic adenocarcinoma 
                         Table 2. Bilateral synchronous breast cancer 
case age right tumor T N TNM operative n Tnm histology adjuvant            l
eft location stage method stage 7 prognosis 
 1 60 right C 2 la II standard 0 I Scjorrpis. 
           left A 2 la II standard la II Solid-tub. Liniac. 10Y 5M alive 
                                                           5FuDs 
                                                        OK432
 2 57 right AEC 2 lb II extended 1,3 if Solid-tub. Liniac. 
           left A 2 0 II extended 0 I Solid-tub. 7Y 5M alive 
                                                             SFuDs 
                                                   MMC
3 45 right AC 2 0 II limited 0 1 Solid-tub. 
          left C 1 0 II limited 0 I Solid-tub. MMC 7Y 1M alive 
                                                           5FuDs 
                                                      TAM 
4 79 right C 2 0 II limited 0 I Papillo tu. 2M alive 
           left CD 2 la II limited 0 I mucinous 
        Solid-tub.: solid-tubular carcinoma Schirrous.: scirrhous carcinoma
 The tumors on the right side were in stage 
II (tumor size from 2.1 to 5cm and nodal in-
volvement of no to nma) (positive metastasis into 
the brachial and subscapular nodes). The 
operative method was standard in one, limited 
in two and extended in one for a patient with 
tumor location of AEC. On the other hand, the 
tumor locations on the left were A in two, C 
in one and CD in one respectively. The opera-
tive methods used were limited in two, standard 
in one and limited in one respectively. Nodal 
involvement was seen in two independently. 
Histologic types were scirrhus carcinoma in one, 
solid-tubular carcinoma in five, papillotubular
in one !and mucinous . in one respectively. 
 As a combined therapy used, irradiation of 
liniac was used in two and 5FU in combination 
with other regimens -was prescribed in three. 
 The prognoses of patients with bilateral syn-
chronous breast cancer were extremely fair, the 
survival time ranging from two months to 10 
years and five months, still living well. 
 The patients with bilateral non-synchronous 
breast cancer were listed in Table 2. The tumor 
locations were not particular when compared 
with those with bilateral synchronous breast 
cancer. In contrast, the disease stages tended 
to be progression. The time interval between
                         Table 3. Bilateral synchronous breast cancer 
           right tumor TNM operative Trim 
case age left location T N stage method n stage histology adjuvant prognosis 
 1 50 left C 3 la III a limited 0 II Papillo tu. MMC 
     50 right C 1 0 1 limited 0 I Papillo tu. MMC 10Y 5M alive 
    (4M) 
2 39 right AEC 4 0 IIIb extended 0 III Papillo tu. Tele Co. 
   (8Y10M) 5Fu
     48 left C 2 lb II standard 0 I Solid-tub. MMC. PSK 11Y 5M alive 
                                  (O'ophrectomy) SFuDs 
                                            MMC
3 42 left C 3 2 IIIa extended 1(3 III Inf. duct. c Liniac. 
   (9M) 5Fu 
     43 right C 1 lb II standard la I Inf. duct. c Liniac. 5Y 4M dead 
                                  (O'ophrectomy) 5Fu 
                                                      OK432
 4 43 right D 1 0 I standard la I Inf. duct. c Liniac. 
   (4Y3M) 5Fu. MMC 
     47 left A 2 lb II O'ophrectomy Inf. duct. c Androgen 6M 1M dead 
 5 53 left AEB 3 2 111a extended 1,8 III Solid-tub. Liniac. 
    (2Y) 5Fu 
     55 right EABCD 3 2 Ma extended 2 III Inf. duct. c Liniac. 4Y 6M dead 
                                  (O'ophrectomy) 5Fu 
                                                        FT207
6 45 left A 1 3 111b extended l.9 II Papillo tu. Liniac. 
   (3Y11M) (O'ophrectomy) 5Fu 
     49 right C 1 2 Ma limited l,. II Solid-tub. Liniac. 5M deac 
                                                             SFuds 
7 43 right C 3 0 Ma extended 1/3 III Papillo tu. Liniac. 
   (9Y11M) 5Fu Ds 
     52 left C 2 0 II limited 0 I Papillo tu. MMC.PSK 5Y 11M alive 
8 40 right AC 2 0 II standard 0 I Solid-tub. MMC 
   (1Y9M) FT207 
     42 left C 1 0 I limited 0 1 Solid-tub. FT207 6Y 1M alive 
       Solid-tub.: solid-tubular carcinoma. Schirrous.: scirrhous carcinoma 
      Inf: duct. c : infiltrating duct carcinoma. papilotu.: papillotubular carcinoma
the two tumors distributed from four months 
to nine years 11 months. The operative methods 
used were standard in four, extended in six and 
limited in five including oophorectomy in one. 
Nodal involvement was seen in five in which 
two were based on unilateral breast cancer, the 
remaining three originated from bilateral one. 
 All patients with bilateral non-synchronous 
breast cancer had the adjuvant therapy of 
chemotherapy and/or irradiation, alone or in 
combination. 
 The prognoses of patients with bilateral non-
synchronous breast cancer were not pessimistic, 
indicating that it depended on progression of
disease stage in each cancer. 
 In this series, three patients with metastatic 
breast cancer were treated as listed in Table 3. 
 Primary cancer was more likely to be ad-
vancing with nodal involvement in all. Extend-
ed and/or standard operations in combination 
with surgical hormone therapy were main as an 
operative method used in this series. Needless 
to say, postoperative adjuvant therapy was 
mandatory. However, the prognosis was very 
poor and all died of recurrence within one year.
         DISCUSSION 
 The definition of bilateral breast cancer is 
divided into the two categories, that is, second 
primary or metastatic. Bilateral primary breast 
cancer is defined in terms of a presence of 
cancer infiltraiton and difference in histologic 
types or a presence of a intraductal and intra-
lobular spread. 
  In addition, synchronous cancers are regarded 
as cancers occurring with the time interval of 
one month as reported by Hojo" and six months 
as reported by Kasumi2'. 
 The incidence of bilateral primary non-syn-
chronous breast cancer is considerably more 
frequent although that of bilateral primary 
synchronous breast cancer has been reported 
to be from about 0.1% to 2.0%. It is accepted 
that the ages of patients with bilateral primary 
breast cancer are under 50 years old. In this 
series, the ages distributed from 25 to 79 with 
an average of 37.3 years old. 
 It is more likely that bilateral breast cancer 
occur in younger patients under 50 years old. 
In case of non-synchronous breast cancer, 
Takatsuka3' reported that the longer the time 
interval between the first and second tumors, 
the longer the survival time. 
 It is plausible that the tumor location is more 
frequently seen in C region as occurs in primary 
cancer'. The operative procedures were inde-
pendently selected according to the disease 
stage of bilateral breast cancers, the extended 
radical operation was carried out for advanced 
cancer and limited operation was selected for 
early cancer. Takahashi4' recommended limit-
ed operation should be preferred as far as 
possible for the reason of functional failure. 
On the other hand, concomitant bilateral opera-
tion is feasible for selected patients by using 
Ratzer' operations'. Controversy over histology 
of bilateral breast cancer revolves around high 
incidence of lobar carcinoma') 4'. 
 It is reproted that histology of bilateral breast 
cancer is characteristic of non-infiltrative mu-
cinous and lymphocyte-infiltrating medullary 
carcinomas'' 7'. Some investigators') ') reported 
that the prognosis of bilateral breast cancer is 
not pessimistic but it is much better rather than
expected. The survival time after surgery for 
bilateral breast cancer depend on the disease 
stage of the first and second tumors. In fact, 
early detection is easier in the second tumor 
rather than in the first tumor. 
 On the other hand, in this series, three pa-
tients with bilateral metastatic cancer under-
went surgery. However, their prognoses were 
very poor. It is believed that the etiology of 
bilateral breast cancer is associated with 
1) abnormality of hormonal enviroment 
2) abnormality of tissue sensitivity to carcino-
gens 
3) possibility of induced cancer by chemother-
apy and irradiation 
4) aberration of postoperative immune state. 
In Europe, random biopsy of mirror image for 
bilateral breast cancer is at times recommended. 
In addition, it is also recommecded that selec-
tive, prophylactic contralateral metastectomy is 
mandatory for bilateral breast cancer'"0' 
 However, on the contrary, Japanese consen-
sus is now hesitate to perform prophylactic 
contralateral mastectomy.
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